Similar articles for PMID: 15883405

Year	Number of Results
1999	1
2000	1
2003	1
2004	1
2005	1
2006	2
2007	3
2008	2
2009	1
2010	3
2011	6
2012	10
2013	10
2014	9
2015	11
2016	9
2017	8
2018	11
2019	6
2021	3
2022	5
2023	8
2024	2

1

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.

Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Hill MD, et al. CMAJ. 2005 May 10;172(10):1307-12. doi: 10.1503/cmaj.1041561. CMAJ. 2005. PMID: 15883405 Free PMC article.

2

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.

Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD; CASES Investigators. Dzialowski I, et al. Stroke. 2007 Jan;38(1):75-9. doi: 10.1161/01.STR.0000251644.76546.62. Epub 2006 Nov 22. Stroke. 2007. PMID: 17122437

3

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.

Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, Ford I, Muir KW. Huang X, et al. Lancet Neurol. 2015 Apr;14(4):368-76. doi: 10.1016/S1474-4422(15)70017-7. Epub 2015 Feb 26. Lancet Neurol. 2015. PMID: 25726502 Clinical Trial.

4

Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.

Zhang B, Sun XJ, Ju CH. Zhang B, et al. Eur Neurol. 2011;65(3):170-4. doi: 10.1159/000324291. Epub 2011 Mar 3. Eur Neurol. 2011. PMID: 21372577 Clinical Trial.

5

Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.

Cappellari M, Moretto G, Micheletti N, Donato F, Tomelleri G, Gulli G, Carletti M, Squintani GM, Zanoni T, Ottaviani S, Romito S, Tommasi G, Musso AM, Deotto L, Gambina G, Zimatore DS, Bovi P. Cappellari M, et al. J Thromb Thrombolysis. 2014 May;37(4):549-56. doi: 10.1007/s11239-013-0980-2. J Thromb Thrombolysis. 2014. PMID: 23943338 Clinical Trial.

6

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).

Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T; J-MARS Investigators. Nakagawara J, et al. Stroke. 2010 Sep;41(9):1984-9. doi: 10.1161/STROKEAHA.110.589606. Epub 2010 Jul 22. Stroke. 2010. PMID: 20651262 Clinical Trial.

7

Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.

Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M; HARP Registry Study Group. Aoki S, et al. J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2747-53. doi: 10.1016/j.jstrokecerebrovasdis.2015.08.005. Epub 2015 Sep 7. J Stroke Cerebrovasc Dis. 2015. PMID: 26360972

8

Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.

Carr SJ, Wang X, Olavarria VV, Lavados PM, Rodriguez JA, Kim JS, Lee TH, Lindley RI, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Woodward M, Chalmers J, Anderson CS, Robinson TG; ENCHANTED Investigators. Carr SJ, et al. Stroke. 2017 Sep;48(9):2605-2609. doi: 10.1161/STROKEAHA.117.017808. Epub 2017 Jul 24. Stroke. 2017. PMID: 28739832

9

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.

Shobha N, Buchan AM, Hill MD; Canadian Alteplase for Stroke Effectiveness Study (CASES). Shobha N, et al. Cerebrovasc Dis. 2011;31(3):223-8. doi: 10.1159/000321893. Epub 2010 Dec 21. Cerebrovasc Dis. 2011. PMID: 21178345

10

Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.

Dorado L, Ahmed N, Thomalla G, Lozano M, Malojcic B, Wani M, Millán M, Tomek A, Dávalos A. Dorado L, et al. Stroke. 2017 Mar;48(3):720-725. doi: 10.1161/STROKEAHA.116.014889. Epub 2017 Feb 7. Stroke. 2017. PMID: 28174326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year